Tomorrow, 16 feb, the United Nations Office of the High Commissioner for Human Rights is organising an expert working group on access to medicines, vaccines and other health products. Health Action International Katrina Perehudoff United NationsHumanRights ohchr.org/sites/default/…

Congratulations, Judit Rius Sanjuan! What an asset for PAHO/WHO and member states!

CALL FOR ABSTRACTS NOW OPEN! Join us at the 2024 Conference on Reproductive Rights: Legal Developments & Challenges, in Amsterdam on May 15-16! Engage with experts Mary Ziegler, Jennifer Merchant, Amrita Pande, Guido de Wert, Heidi Mertes & Michele Goodwin
bit.ly/3Uw7Mol

3-day World Health Organization (WHO) Fair Pricing Forum wraps up! Honoured to speak in last plenary on governance & the 3 Cs: Cooperation for norm setting, Clarity on prices, Capacity-building watchdogs to monitor & intervene in pharma market. Veronika Wirtz Zaheer Babar Instituto de Evaluación Tecnológica en Salud Roche

Join us for this book launch! The book is a key contribution to debates on EU democracy, not least through the original notion of ‘decolonial multitude’.

Join our UACES conference track in Trento, 1-4 Sept 2024! The panels aim to provide an open yet critical space for scholars working on Europe outside the main disciplinary currents of European Studies. Submission deadline is 21 January

Pharma regulatory systems of tomorrow would benefit from a global competency framework. This would increase #HumanCapacities in low-income settings. Still major challenge to attract and retain talent - Luther Gwaza World Health Organization (WHO) Utrecht University

Excited for Utrecht University World Health Organization (WHO) Winter Pharma Meeting starting today. Even better, Christine Leopold joins Utrecht University’s pharma faculty & speaks today on primary health care. So great for UU to attract this talented policy researcher!

Today debating EU #pharma review at annual conf Cop. Centre for Regulatory Science. MEP Pernille Weiss now on her proposal —a ‘renaissance for EU competitiveness’, already heard Adrian van den Hoven, my call for considering global ‘side effects’ of EU pharma law, EFPIA , & EURORDIS-Rare Diseases Europe

A big congratulations to Christina Eckes from Amsterdam Centre for European Law and Governance for being awarded the prestigious European Research Council (ERC) Consolidator grant! 🙌 go.uva.nl/3um3jta

Thanks Michele Goodwin for an inspiring talk today about the stories told in the law💫and to Bahar Goodarzi & Lilianne Ploumen for bringing in the Dutch perspectives on equality and health in the NL! Thanks to the Health Law students❤️🔥of Amsterdam Law School UvA Amsterdam

AIGHD Great to be part of this session organised by European Global Health Research Institutes Network! Implementing the #EUGlobalHealthStrategy will require a (global) health in all policies approach, incl. the #EUPharmaStrategy - which currently still neglects the global dimensions of health.

What research is still lacking in the field of #access to #medicines ? At ECTMIH2023, Prof. Fatima Suleman shares her experience, and calls for #fair pricing, #Equality , non-discrimination, #transparency

Important topics now ECTMIH2023: 1. Rosalind Turkie on corporate accountability for #vaccine access via #FairFarma scorecard Stichting Farma ter Verantwoording 2. Raffaella Ravinetto on educational innovation to break silos via intensive #pharma policy course Institute of Tropical Medicine Antwerp. Proud to be a small part of both!

In Copenhagen on Nov 24? Join me @ Cop. Centre for Regulatory Science annual conf on EU #pharma review. Keen to speak about the global ‘side effects’ of #EU pharma law, alongside DK Medicines Agency MEP Pernille Weiss Adrian van den Hoven Medicines for Europe EURORDIS-Rare Diseases Europe EFPIA cors.ku.dk/announcements/…

Catching up with old friends & making new connections ECTMIH2023 now asking ‘where is the insulin?’ w. my dear PhD supervisor Hans Hogerzeil and Health Action International ACCISS study. Raffaella Ravinetto Prof. Fatima Suleman Stichting Farma ter Verantwoording

In a world first, the UK medicines regulator has approved a therapy that uses CRISPR gene editing as a treatment for diseases go.nature.com/3QDtwuV